Huvepharma Unveils New Tilmicosin Product
July 3, 2013 —
Huvepharma is excited to announce that it is marketing its new product Tilmovet® (tilmicosin phosphate). This product adds to Huvepharma’s rapidly growing swine products portfolio. Tilmovet is now available as an 18 g/lb. Type B medicated feed and as a 90 g/lb Type A medicated article.
Tilmovet is registered for use as a veterinary feed directive (VFD) drug for the control of swine respiratory disease associated with Actinobacillus pleuropneumoniae and Pasteurella multocida. Veterinarians can manage VFDs electronically as a complimentary service from Huvepharma by accessing http://www.globalvetlink.com or request VFD forms directly from Huvepharma’s customer service department.
Customers may place orders with your area Huvepharma representative, Customer Service at (877)-994-4883, or email: mailto: customerservice@huvepharma.us.
Source: PorkNetwork News Source, 07/01/2013
- Next story: Denmark: Only 450 breeding farms remaining
- Next in category: Avoiding Penicillin G Residues Requires Extended Withdrawal
- Previous in category: Fighting the Impact of Antibiotic-Resistant Bacteria
- Previous story: First H3N2v Outbreak of 2013 Reported; CDC Continues to Urge High Risk People to Avoid Swine at Fairs